Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion

QR Code

Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion

AIM: To observe the therapeutic efficacy of intravitreal injection of conbercept for macular edema in different types of retinal vein occlusion(RVO).METHODS: Retrospective cohort study of 79 patients 79 eyes in different types of RVO(BRVO:54; non-ischemic CRVO: 16; ischemic CRVO: 9)received intravit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peng-Yao Lin, Yan Shi, Bo Li, Yi-Meng Ruan, Shan-Shan Hua
Format:	article
Language:	EN
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2021
Subjects:	retinal vein occlusion macular edema conbercept anti-vegf Ophthalmology RE1-994
Online Access:	https://doaj.org/article/a7e72d91e60b4fc886a730847b5ebc29
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of anti-VEGF therapy combined with iontophoresis of Xueshuantong injection on retinal vein obstruction with macular edema
by: Zi-Yue Xiang, et al.
Published: (2021)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
by: Laine I, et al.
Published: (2017)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
by: Paulose R, et al.
Published: (2016)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
by: Ivanovska Adjievska B, et al.
Published: (2017)

Vitrectomy for macular edema due to retinal vein occlusion
by: Kumagai K, et al.
Published: (2019)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
by: Takeyama M, et al.
Published: (2017)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
by: Andrzej Grzybowski, et al.
Published: (2021)

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
by: Oellers P, et al.
Published: (2016)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
by: Tsai MJ, et al.
Published: (2018)

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
by: Michalska-Małecka K, et al.
Published: (2016)

Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
by: Kawamura M, et al.
Published: (2018)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
by: Tagami M, et al.
Published: (2017)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
by: Kumagai K, et al.
Published: (2019)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
by: Sivaprasad S, et al.
Published: (2016)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
by: Callizo J, et al.
Published: (2019)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
by: Sakanishi Y, et al.
Published: (2017)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
by: Singer MA, et al.
Published: (2016)

Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion
by: Nishida A, et al.
Published: (2017)

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
by: Kartasasmita AS, et al.
Published: (2016)

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion
by: I. V. Zlobin, et al.
Published: (2019)

Bilateral retinal hemorrhages and macular edema in a patient with dengue fever associated with cerebral hemorrhage
by: Rajesh Subhash Joshi, et al.
Published: (2021)

Morphologic Classifications and Locations of Microaneurysms and Clinical Relevance in Branch Retinal Vein Occlusion
by: Esaki Y, et al.
Published: (2020)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
by: Wallsh J, et al.
Published: (2020)

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
by: Jumper JM, et al.
Published: (2018)

A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study
by: Karagiannis DA, et al.
Published: (2020)

Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments
by: Shirakata Y, et al.
Published: (2016)

Central retinal vein occlusion and pseudoexfoliation syndrome
by: Karagiannis D, et al.
Published: (2015)

Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
by: Qi Zhang, et al.
Published: (2021)

Dexamethasone implant in retinal vein occlusions
by: Han SB, et al.
Published: (2016)

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
by: Zhuang Cui, et al.
Published: (2021)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
by: Hall J
Published: (2016)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
by: Tran THC, et al.
Published: (2021)

Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
by: Sakanishi Y, et al.
Published: (2016)

Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
by: Narayanan R, et al.
Published: (2016)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
by: Kim MS, et al.
Published: (2021)

Diagnostic Criteria for Macular Edema Associated with Venous Occlusions
by: A. G. Shchuko, et al.
Published: (2020)

Effect of intravitreal aflibercept on corneal endothelial cells: a 6-month follow-up study
by: Muto T, et al.
Published: (2019)

Retinal vein occlusion with cerebral infarction in a preterm neonate: a case report
by: Xiuyu Zhu, et al.
Published: (2021)

Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
by: Cui C, et al.
Published: (2017)

Systemic abnormalities associated with retinal vein occlusion in young patients
by: Sinawat S, et al.
Published: (2017)